Cargando…

Treatment of Liver Fibrosis: A 20-Year Bibliometric and Knowledge-Map Analysis

Objectives: To analyze the research hotspots, evolution, and trends of the treatment of liver fibrosis in the recent 20 years, bibliometric and knowledge-map analysis were used. Methods: Publications associated with the treatment of liver fibrosis were retrieved from the Web of Science Core Collecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Yun-Kai, Zhao, Zhi-Min, Liu, Chenghai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315937/
https://www.ncbi.nlm.nih.gov/pubmed/35903335
http://dx.doi.org/10.3389/fphar.2022.942841
_version_ 1784754684178726912
author Dai, Yun-Kai
Zhao, Zhi-Min
Liu, Chenghai
author_facet Dai, Yun-Kai
Zhao, Zhi-Min
Liu, Chenghai
author_sort Dai, Yun-Kai
collection PubMed
description Objectives: To analyze the research hotspots, evolution, and trends of the treatment of liver fibrosis in the recent 20 years, bibliometric and knowledge-map analysis were used. Methods: Publications associated with the treatment of liver fibrosis were retrieved from the Web of Science Core Collection on 16 April 2022. CiteSpace 5.8.R3 and VOSviewer 1.6.18 were calculated to perform bibliometric and knowledge-map analysis. Results: A total of 72,686 authors from 200 institutions in 134 countries/regions published 15,237 studies in different academic journals. United States was the most productive country, and Shanghai Jiao Tong University was the most published institution. Trauner Michael had the most published articles, whereas Scott L. Friedman was the most frequently co-cited author. Moreover, there was frequent inter-institution cooperation between countries in the years 2015 and after, but the before years showed rare inter-institution cooperation. The journal HEPATOLOGY was both the most published publication and the most frequently co-cited one in this field. Screened keywords, such as virus infection, inflammation, oxidative stress, activation of hepatic stellate cell (HSC), and hepatocellular apoptosis, could be both therapeutic targets and pathological mechanisms in terms of liver fibrosis. Furthermore, long-term suppression of hepatitis B virus replication and the activation of HSC were the latest hotspots and topics related to the treatment of liver fibrosis. Besides, the treatments of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis were also involved in the treatment of liver fibrosis, which were both emerging topics and rapidly developing hot fields. Conclusion: This bibliometric analysis conducted a full overview of the treatment of liver fibrosis, which provided important clues and ideas for scholars focusing on this field. Not only that, the field is still in a stage of rapid development and will continue to be a research hotspot in the future.
format Online
Article
Text
id pubmed-9315937
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-93159372022-07-27 Treatment of Liver Fibrosis: A 20-Year Bibliometric and Knowledge-Map Analysis Dai, Yun-Kai Zhao, Zhi-Min Liu, Chenghai Front Pharmacol Pharmacology Objectives: To analyze the research hotspots, evolution, and trends of the treatment of liver fibrosis in the recent 20 years, bibliometric and knowledge-map analysis were used. Methods: Publications associated with the treatment of liver fibrosis were retrieved from the Web of Science Core Collection on 16 April 2022. CiteSpace 5.8.R3 and VOSviewer 1.6.18 were calculated to perform bibliometric and knowledge-map analysis. Results: A total of 72,686 authors from 200 institutions in 134 countries/regions published 15,237 studies in different academic journals. United States was the most productive country, and Shanghai Jiao Tong University was the most published institution. Trauner Michael had the most published articles, whereas Scott L. Friedman was the most frequently co-cited author. Moreover, there was frequent inter-institution cooperation between countries in the years 2015 and after, but the before years showed rare inter-institution cooperation. The journal HEPATOLOGY was both the most published publication and the most frequently co-cited one in this field. Screened keywords, such as virus infection, inflammation, oxidative stress, activation of hepatic stellate cell (HSC), and hepatocellular apoptosis, could be both therapeutic targets and pathological mechanisms in terms of liver fibrosis. Furthermore, long-term suppression of hepatitis B virus replication and the activation of HSC were the latest hotspots and topics related to the treatment of liver fibrosis. Besides, the treatments of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis were also involved in the treatment of liver fibrosis, which were both emerging topics and rapidly developing hot fields. Conclusion: This bibliometric analysis conducted a full overview of the treatment of liver fibrosis, which provided important clues and ideas for scholars focusing on this field. Not only that, the field is still in a stage of rapid development and will continue to be a research hotspot in the future. Frontiers Media S.A. 2022-07-12 /pmc/articles/PMC9315937/ /pubmed/35903335 http://dx.doi.org/10.3389/fphar.2022.942841 Text en Copyright © 2022 Dai, Zhao and Liu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Dai, Yun-Kai
Zhao, Zhi-Min
Liu, Chenghai
Treatment of Liver Fibrosis: A 20-Year Bibliometric and Knowledge-Map Analysis
title Treatment of Liver Fibrosis: A 20-Year Bibliometric and Knowledge-Map Analysis
title_full Treatment of Liver Fibrosis: A 20-Year Bibliometric and Knowledge-Map Analysis
title_fullStr Treatment of Liver Fibrosis: A 20-Year Bibliometric and Knowledge-Map Analysis
title_full_unstemmed Treatment of Liver Fibrosis: A 20-Year Bibliometric and Knowledge-Map Analysis
title_short Treatment of Liver Fibrosis: A 20-Year Bibliometric and Knowledge-Map Analysis
title_sort treatment of liver fibrosis: a 20-year bibliometric and knowledge-map analysis
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315937/
https://www.ncbi.nlm.nih.gov/pubmed/35903335
http://dx.doi.org/10.3389/fphar.2022.942841
work_keys_str_mv AT daiyunkai treatmentofliverfibrosisa20yearbibliometricandknowledgemapanalysis
AT zhaozhimin treatmentofliverfibrosisa20yearbibliometricandknowledgemapanalysis
AT liuchenghai treatmentofliverfibrosisa20yearbibliometricandknowledgemapanalysis